Zoekresultaten - 89 results

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

Cuschieri, Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among under-screened women. Methods A systematic review and meta-analysis on randomised ...

Couverture vaccinale des vaccinations de base

vaccin rougeole-oreillons-rubéole, la couverture vaccinale dans les trois régions est inférieure au seuil de 95% recommandée par l’ OMS. Pour le HPV, le taux national de couverture vaccinale pour une ...

Vaccinatiegraad van basisvaccinaties

HPV ligt de nationale vaccinatiegraad voor volledige vaccinatie bij meisjes van 15 jaar (69,3%) lager dan de doelstelling van de WGO om baarmoederhalskanker te elimineren (≥ 90%). Health Topics:  ...

HPV and head and neck cancers: Towards early diagnosis and prevention.

viral infections, such as the mucosal high-risk (HR) human papillomaviruses (HPV s) are major risk factors for HNSCC development. In particular, HR HPV s are mainly associated with a subset of ...

Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework

clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...

Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.

safety of prophylactic HPV vaccines derived from randomized trials was published in the Cochrane database of Systematic reviews. A summary of this Cochrane review is presented below. Areas covered: Only ...

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.

cervical precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES: The VALHUDES protocol is designed as a diagnostic test accuracy study that ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. VALGENT is designed to assess ...

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of ...

QR code

QR code for this page URL